Description |
N-acetyltransferase 2 |
APC regulator of WNT signaling pathway |
Image |
|
|
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Apolipoprotein A1 levels ( 32203549)
- Apolipoprotein B levels ( 32203549)
- Bladder cancer ( 24163127 20972438)
- Blood metabolite levels ( 24816252)
- Blood metabolite ratios ( 24816252)
- Cholesterol, total ( 24097068 20686565)
- Coronary artery disease ( 29212778 33020668)
- Gut microbiota (bacterial taxa, hurdle binary method) ( 32572223)
- Insulin resistance/response ( 25798622)
- Iron status biomarkers (transferrin levels) ( 25352340)
- LDL cholesterol levels ( 32203549)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Liver injury in anti-tuberculosis drug treatment ( 31109976)
- Medication use (calcium channel blockers) ( 31015401)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Metabolic syndrome ( 31589552)
- Metabolic traits ( 21886157)
- Metabolite levels ( 23823483)
- Night sleep phenotypes ( 27126917)
- Paclitaxel-induced neuropathy ( 23776197)
- Total cholesterol levels ( 28334899)
- Triglyceride levels ( 32203549 28334899 29403010 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x long total sleep time interaction (2df test) ( 31719535)
- Triglyceride levels x short total sleep time interaction (2df test) ( 31719535)
- Triglycerides ( 24097068 20686565)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
- Urinary metabolite modules (eigenmetabolites) in chronic kidney disease ( 31959995)
- Urinary metabolites ( 26352407 21572414)
- Urinary metabolites (H-NMR features) ( 24586186)
- Youthful appearance (self-reported) ( 32339537)
|
- Angiotensin-converting enzyme inhibitor intolerance ( 28030426)
- Body mass index ( 29273807)
- Colorectal cancer or advanced adenoma ( 30510241)
- Heel bone mineral density ( 30598549)
- Reaction time ( 29844566)
- Total body bone mineral density ( 29304378)
|
Interacting Genes |
17 interacting genes:
APC
APP
AURKA
BAG4
CDKN2A
CDKN2C
ERBB2
FZR1
HMMR
IGF1R
MBD4
NAA10
NBN
PALB2
PPM1D
STK11
WT1
|
138 interacting genes:
ACTN1
ADGRL1
AGFG1
AGR3
ANKRD17
ANP32B
ANXA7
AP2B1
ARHGEF4
ASAP2
AXIN1
AXIN2
BAAT
BUB1
BUB1B
C4A
CASC3
CCL5
CGNL1
COG4
COG5
CREBBP
CSNK1A1
CSNK1E
CTBP1
CTNNA1
CTNNB1
CTSV
CYP17A1
CYTH2
DIRAS3
DKK3
DLG3
DLGAP1
DST
EPAS1
ERBIN
EXPH5
FAM214A
FANCC
FBP1
FBXO30
FHOD1
FLNA
GIGYF2
GOLGA2
GSK3B
HGS
HNRNPM
HOXC6
HSPA5
HTRA2
IL24
ING5
IQGAP1
JUP
KIAA1328
KIF5B
KIFAP3
KRT13
KRT14
KRT15
KRT17
KRT19
KRT23
KRT5
LAMA3
LAMA4
MACF1
MAP2K1
MAPRE1
MAPRE2
MBD5
MCM3AP
MKRN1
MT-ND4
MUC1
MYH10
MYH11
MYO6
NANS
NAT2
NAV1
NAV2
NAV3
NCKAP5
NCKAP5L
NEB
NOSTRIN
NUP153
NUP214
NUP42
NUP54
NUP58
NUP98
PDLIM2
PNISR
POM121
POM121C
PPP1R13B
PPP2CA
PPP2R5A
PPP3R2
PRKACA
PSMD1
PTPN13
RANBP9
RASA1
RBM4B
RP1
RPS27
SCRIB
SEC31A
SETDB1
SIAH1
SMAD1
SMC3
SNRNP200
SPECC1L
SPTBN1
SPTBN2
ST14
SYNE1
TAF1
TFAP2A
TFF1
TGFB1
TMEFF1
TMOD1
TPR
TRIM21
TRIM25
TSTD2
TUBA4A
XPO1
YWHAQ
ZNF106
ZNF510
|
Entrez ID |
10 |
324 |
HPRD ID |
02000 |
01439 |
Ensembl ID |
ENSG00000156006
|
ENSG00000134982
|
Uniprot IDs |
A4Z6T7
P11245
|
P25054
Q4LE70
|
PDB IDs |
2PFR
|
1DEB
1EMU
1JPP
1M5I
1T08
1TH1
1V18
2RQU
3AU3
3NMW
3NMX
3NMZ
3QHE
3RL7
3RL8
3T7U
4G69
4YJE
4YJL
4YK6
5B6G
5IZ6
5IZ8
5IZ9
5IZA
5Z8H
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|